Información*
| Nombre | OSCAR GERARDO ARRIETA RODRIGUEZ |
|---|---|
| Área | MEDICINA Y CIENCIAS DE LA SALUD |
| Campo | ESPECIALIDAD MÉDICA |
| Disciplina | ONCOLOGÍA |
| Especialidad | ONCOLOGIA |
| CVU | 20556 |
| Institución | |
|---|---|
| Dependencia | DIVISION DE INVESTIGACION CLINICA |
| Entidad | CIUDAD DE MEXICO |
| Nivel | 3 |
| Vigencia | Inicio: 01/01/2024 |
| Fin: 31/12/2033 |
* Información del primer trimestre de 2026.
Fuente: SECIHTI.
Publicaciones ORCID
- 2026
- DNA damage response genes in lung cancer: Diagnostic, prognostic, and therapeutic implications – A narrative review Critical Reviews in Oncology/Hematology
- Mitochondrial DNA in lung cancer: From biology to clinical implications Critical Reviews in Oncology/Hematology
- Independent Cancer Research in Low- and Middle-Income Countries: Why it matters and how to build it.
- Data from Cancer Incidence and Mortality Estimates in Latin America and the Caribbean: A Systematic Analysis of the GLOBOCAN 2022
- Figure 1 from Cancer Incidence and Mortality Estimates in Latin America and the Caribbean: A Systematic Analysis of the GLOBOCAN 2022
- Figure 2 from Cancer Incidence and Mortality Estimates in Latin America and the Caribbean: A Systematic Analysis of the GLOBOCAN 2022
- Figure 3 from Cancer Incidence and Mortality Estimates in Latin America and the Caribbean: A Systematic Analysis of the GLOBOCAN 2022
- Figure 4 from Cancer Incidence and Mortality Estimates in Latin America and the Caribbean: A Systematic Analysis of the GLOBOCAN 2022
- Supplementary Figure S1 from Cancer Incidence and Mortality Estimates in Latin America and the Caribbean: A Systematic Analysis of the GLOBOCAN 2022
- Supplementary Figure S2 from Cancer Incidence and Mortality Estimates in Latin America and the Caribbean: A Systematic Analysis of the GLOBOCAN 2022